T2 Biosystems’ stock extends losing streak despite FDA approval for anthrax and plague diagnostic test
September 20, 2023 at 16:50 PM EDT
Shares of T2 Biosystems extended their losing streak to two days Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|